Align Technology Announces Fourth Quarter and Fiscal 20...(statements for any reason. ALIGN TE...),Health

    ALIGN TECHNOLOGY, INC.
    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (in thousands, except per share data)


                                         Three Months Ended     Year Ended
                                         December December  December  December
                                            31,      31,       31,       31,
                                           2008     2007      2008      2007

    Net revenues                          $74,125  $72,517  303,976  $284,332

    Cost of revenues                       20,233   19,127   78,850    75,035

    Gross profit                           53,892   53,390  225,126   209,297

    Operating expenses:
     Sales and marketing                   26,325   26,502  115,062    98,231
     General and administrative            16,249   15,266   62,154    53,280
     Research and development               5,951    6,610   26,165    25,727
     Restructuring                          4,042             6,231         -
     Patients First Program                   -          -      -      (1,796)


    Total operating expenses               52,567   48,378  209,612   175,442


    Profit from operations                  1,325    5,012   15,514    33,855

    Interest and other income (expense),
     net                                     (111)     852    1,562     3,095

    Profit before income taxes               1,214    5,864  17,076    36,950

    Provision for (benefit from) income
     taxes                                (64,282)     196  (62,911)    1,226

    Net profit                            $65,496   $5,668  $79,987   $35,724

    Net profit per share
         - basic                            $0.99    $0.08    $1.20     $0.53
         - diluted                          $0.98    $0.08    $1.18     $0.50

    Shares used in computing net profit
     per share
         - basic    
'/>"/>
SOURCE  Align Technology
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Related medicine news :

1. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
2. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
3. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
4. FDA Clears Expanded Labeling for the Invisalign System
5. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
6. Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
7. Align Technology Announces Third Quarter Fiscal 2008 Results
8. 5- and 10-year survival continues to improve for US children with hematologic malignancies
9. SpectraScience Awarded Patent for Correcting Image Misalignment
10. Align Technology Announces Second Quarter Fiscal 2008 Results
11. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)